UTHEALTH HOME    ABOUT SBMI    A-Z    WEBMAIL    INSIDE THE UNIVERSITY
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine level1
leaf

Fusion Gene Summary

leaf

Fusion Gene Sample Information

leaf

Fusion ORF Analysis

leaf

Fusion Amino Acid Sequences

leaf

Fusion Protein Functional Features

leaf

Fusion Protein-Protein Interaction

leaf

Related drugs with this fusion protein

leaf

Related disease with this fusion protein

Fusion Protein:PTGFRN-NOTCH2

Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PTGFRN-NOTCH2
FusionPDB ID: 69993
FusionGDB2.0 ID: 69993
HgeneTgene
Gene symbol

PTGFRN

NOTCH2

Gene ID

5738

4853

Gene nameprostaglandin F2 receptor inhibitornotch receptor 2
SynonymsCD315|CD9P-1|EWI-F|FPRP|SMAP-6AGS2|HJCYS|hN2
Cytomap

1p13.1

1p12

Type of geneprotein-codingprotein-coding
Descriptionprostaglandin F2 receptor negative regulatorCD9 partner 1glu-Trp-Ile EWI motif-containing protein Fprostaglandin F2-alpha receptor regulatory proteinprostaglandin F2-alpha receptor-associated proteinneurogenic locus notch homolog protein 2Notch homolog 2notch 2
Modification date2020031320200329
UniProtAcc.

P0DPK3

Ensembl transtripts involved in fusion geneENST idsENST00000393203, ENST00000496699, 
ENST00000493703, ENST00000602566, 
ENST00000256646, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score7 X 6 X 3=12613 X 10 X 6=780
# samples 714
** MAII scorelog2(7/126*10)=-0.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(14/780*10)=-2.47804729680464
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context (manual curation of fusion genes in FusionPDB)

PubMed: PTGFRN [Title/Abstract] AND NOTCH2 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PTGFRN(117492194)-NOTCH2(120512367), # samples:3
Anticipated loss of major functional domain due to fusion event.PTGFRN-NOTCH2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTGFRN-NOTCH2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTGFRN-NOTCH2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PTGFRN-NOTCH2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneNOTCH2

GO:0007050

cell cycle arrest

11306509

TgeneNOTCH2

GO:0007219

Notch signaling pathway

11306509|25985737

TgeneNOTCH2

GO:0010629

negative regulation of gene expression

11306509

TgeneNOTCH2

GO:0010838

positive regulation of keratinocyte proliferation

18469519

TgeneNOTCH2

GO:0045967

negative regulation of growth rate

11306509

TgeneNOTCH2

GO:0046579

positive regulation of Ras protein signal transduction

11306509

TgeneNOTCH2

GO:0070374

positive regulation of ERK1 and ERK2 cascade

11306509

TgeneNOTCH2

GO:2000249

regulation of actin cytoskeleton reorganization

18469519


check buttonFusion gene breakpoints across PTGFRN (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NOTCH2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Gene Sample Information

check buttonFusion gene information from FusionGDB2.0.
check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4BRCATCGA-C8-A12L-01APTGFRNchr1

117492194

-NOTCH2chr1

120512367

-
ChimerDB4BRCATCGA-C8-A12L-01APTGFRNchr1

117492194

+NOTCH2chr1

120512367

-


Top

Fusion ORF Analysis


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000393203PTGFRNchr1117492194+ENST00000256646NOTCH2chr1120512367-11655136014779012584

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000393203ENST00000256646PTGFRNchr1117492194+NOTCH2chr1120512367-0.0010047780.99899524

Top

Fusion Amino Acid Sequences


check button For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

>69993_69993_1_PTGFRN-NOTCH2_PTGFRN_chr1_117492194_ENST00000393203_NOTCH2_chr1_120512367_ENST00000256646_length(amino acids)=2584AA_BP=876
MGRLASRPLLLALLSLALCRGRVVRVPTATLVRVVGTELVIPCNVSDYDGPSEQNFDWSFSSLGSSFVELASTWEVGFPAQLYQERLQRG
EILLRRTANDAVELHIKNVQPSDQGHYKCSTPSTDATVQGNYEDTVQVKVLADSLHVGPSARPPPSLSLREGEPFELRCTAASASPLHTH
LALLWEVHRGPARRSVLALTHEGRFHPGLGYEQRYHSGDVRLDTVGSDAYRLSVSRALSADQGSYRCIVSEWIAEQGNWQEIQEKAVEVA
TVVIQPSVLRAAVPKNVSVAEGKELDLTCNITTDRADDVRPEVTWSFSRMPDSTLPGSRVLARLDRDSLVHSSPHVALSHVDARSYHLLV
RDVSKENSGYYYCHVSLWAPGHNRSWHKVAEAVSSPAGVGVTWLGQFCTEDVDECLLQPNACQNGGTCANRNGGYGCVCVNGWSGDDCSE
NIDDCAFASCTPGSTCIDRVASFSCMCPEGKAGLLCHLDDACISNPCHKGALCDTNPLNGQYICTCPQGYKGADCTEDVDECAMANSNPC
EHAGKCVNTDGAFHCECLKGYAGPRCEMDINECHSDPCQNDATCLDKIGGFTCLCMPGFKGVHCELEINECQSNPCVNNGQCVDKVNRFQ
CLCPPGFTGPVCQIDIDDCSSTPCLNGAKCIDHPNGYECQCATGFTGVLCEENIDNCDPDPCHHGQCQDGIDSYTCICNPGYMGAICSDQ
IDECYSSPCLNDGRCIDLVNGYQCNCQPGTSGVNCEINFDDCASNPCIHGICMDGINRYSCVCSPGFTGQRCNIDIDECASNPCRKGATC
INGVNGFRCICPEGPHHPSCYSQVNECLSNPCIHGNCTGGLSGYKCLCDAGWVGINCEVDKNECLSNPCQNGGTCDNLVNGYRCTCKKGF
KGYNCQVNIDECASNPCLNQGTCFDDISGYTCHCVLPYTGKNCQTVLAPCSPNPCENAAVCKESPNFESYTCLCAPGWQGQRCTIDIDEC
ISKPCMNHGLCHNTQGSYMCECPPGFSGMDCEEDIDDCLANPCQNGGSCMDGVNTFSCLCLPGFTGDKCQTDMNECLSEPCKNGGTCSDY
VNSYTCKCQAGFDGVHCENNINECTESSCFNGGTCVDGINSFSCLCPVGFTGSFCLHEINECSSHPCLNEGTCVDGLGTYRCSCPLGYTG
KNCQTLVNLCSRSPCKNKGTCVQKKAESQCLCPSGWAGAYCDVPNVSCDIAASRRGVLVEHLCQHSGVCINAGNTHYCQCPLGYTGSYCE
EQLDECASNPCQHGATCSDFIGGYRCECVPGYQGVNCEYEVDECQNQPCQNGGTCIDLVNHFKCSCPPGTRGLLCEENIDDCARGPHCLN
GGQCMDRIGGYSCRCLPGFAGERCEGDINECLSNPCSSEGSLDCIQLTNDYLCVCRSAFTGRHCETFVDVCPQMPCLNGGTCAVASNMPD
GFICRCPPGFSGARCQSSCGQVKCRKGEQCVHTASGPRCFCPSPRDCESGCASSPCQHGGSCHPQRQPPYYSCQCAPPFSGSRCELYTAP
PSTPPATCLSQYCADKARDGVCDEACNSHACQWDGGDCSLTMENPWANCSSPLPCWDYINNQCDELCNTVECLFDNFECQGNSKTCKYDK
YCADHFKDNHCDQGCNSEECGWDGLDCAADQPENLAEGTLVIVVLMPPEQLLQDARSFLRALGTLLHTNLRIKRDSQGELMVYPYYGEKS
AAMKKQRMTRRSLPGEQEQEVAGSKVFLEIDNRQCVQDSDHCFKNTDAAAALLASHAIQGTLSYPLVSVVSESLTPERTQLLYLLAVAVV
IILFIILLGVIMAKRKRKHGSLWLPEGFTLRRDASNHKRREPVGQDAVGLKNLSVQVSEANLIGTGTSEHWVDDEGPQPKKVKAEDEALL
SEEDDPIDRRPWTQQHLEAADIRRTPSLALTPPQAEQEVDVLDVNVRGPDGCTPLMLASLRGGSSDLSDEDEDAEDSSANIITDLVYQGA
SLQAQTDRTGEMALHLAARYSRADAAKRLLDAGADANAQDNMGRCPLHAAVAADAQGVFQILIRNRVTDLDARMNDGTTPLILAARLAVE
GMVAELINCQADVNAVDDHGKSALHWAAAVNNVEATLLLLKNGANRDMQDNKEETPLFLAAREGSYEAAKILLDHFANRDITDHMDRLPR
DVARDRMHHDIVRLLDEYNVTPSPPGTVLTSALSPVICGPNRSFLSLKHTPMGKKSRRPSAKSTMPTSLPNLAKEAKDAKGSRRKKSLSE
KVQLSESSVTLSPVDSLESPHTYVSDTTSSPMITSPGILQASPNPMLATAAPPAPVHAQHALSFSNLHEMQPLAHGASTVLPSVSQLLSH
HHIVSPGSGSAGSLSRLHPVPVPADWMNRMEVNETQYNEMFGMVLAPAEGTHPGIAPQSRPPEGKHITTPREPLPPIVTFQLIPKGSIAQ
PAGAPQPQSTCPPAVAGPLPTMYQIPEMARLPSVAFPTAMMPQQDGQVAQTILPAYHPFPASVGKYPTPPSQHSYASSNAAERTPSHSGH

--------------------------------------------------------------

Top

Fusion Protein Functional Features


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:117492194/chr1:120512367)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
.NOTCH2

P0DPK3

FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.FUNCTION: Human-specific protein that promotes neural progenitor proliferation and evolutionary expansion of the brain neocortex by regulating the Notch signaling pathway (PubMed:29856954, PubMed:29856955, PubMed:29561261). Able to promote neural progenitor self-renewal, possibly by down-regulating neuronal differentiation genes, thereby delaying the differentiation of neuronal progenitors and leading to an overall final increase in neuronal production (PubMed:29856954, PubMed:29856955). Acts by enhancing the Notch signaling pathway via two different mechanisms that probably work in parallel to reach the same effect (PubMed:29856954, PubMed:29856955). Enhances Notch signaling pathway in a non-cell-autonomous manner via direct interaction with NOTCH2 (PubMed:29856954). Also promotes Notch signaling pathway in a cell-autonomous manner through inhibition of cis DLL1-NOTCH2 interactions, which promotes neuronal differentiation (PubMed:29856955). {ECO:0000269|PubMed:29561261, ECO:0000269|PubMed:29856954, ECO:0000269|PubMed:29856955}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

* Minus value of BPloci means that the break pointn is located before the CDS.
- Retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49149_268404.3333333333333880.0DomainNote=Ig-like C2-type 2
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+4926_129404.3333333333333880.0DomainNote=Ig-like C2-type 1
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49276_394404.3333333333333880.0DomainNote=Ig-like C2-type 3
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341645_1648291.33333333333332472.0Compositional biasNote=Poly-Ala
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341994_1997291.33333333333332472.0Compositional biasNote=Poly-Leu
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464342426_2429291.33333333333332472.0Compositional biasNote=Poly-Ser
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341025_1061291.33333333333332472.0DomainEGF-like 27%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341063_1099291.33333333333332472.0DomainEGF-like 28
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341101_1147291.33333333333332472.0DomainEGF-like 29
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341149_1185291.33333333333332472.0DomainEGF-like 30%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341187_1223291.33333333333332472.0DomainEGF-like 31%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341225_1262291.33333333333332472.0DomainEGF-like 32%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341264_1302291.33333333333332472.0DomainEGF-like 33
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341304_1343291.33333333333332472.0DomainEGF-like 34
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341374_1412291.33333333333332472.0DomainEGF-like 35
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434298_336291.33333333333332472.0DomainEGF-like 8%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434338_374291.33333333333332472.0DomainEGF-like 9%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434375_413291.33333333333332472.0DomainEGF-like 10
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434415_454291.33333333333332472.0DomainEGF-like 11%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434456_492291.33333333333332472.0DomainEGF-like 12%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434494_530291.33333333333332472.0DomainEGF-like 13%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434532_568291.33333333333332472.0DomainEGF-like 14%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434570_605291.33333333333332472.0DomainEGF-like 15%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434607_643291.33333333333332472.0DomainEGF-like 16%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434645_680291.33333333333332472.0DomainEGF-like 17%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434682_718291.33333333333332472.0DomainEGF-like 18%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434720_755291.33333333333332472.0DomainEGF-like 19
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434757_793291.33333333333332472.0DomainEGF-like 20%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434795_831291.33333333333332472.0DomainEGF-like 21%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434833_871291.33333333333332472.0DomainEGF-like 22
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434873_909291.33333333333332472.0DomainEGF-like 23%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434911_947291.33333333333332472.0DomainEGF-like 24%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434949_985291.33333333333332472.0DomainEGF-like 25%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434987_1023291.33333333333332472.0DomainEGF-like 26%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341425_1677291.33333333333332472.0RegionNote=Negative regulatory region (NRR)
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341425_1465291.33333333333332472.0RepeatNote=LNR 1
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341466_1502291.33333333333332472.0RepeatNote=LNR 2
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341503_1544291.33333333333332472.0RepeatNote=LNR 3
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341827_1871291.33333333333332472.0RepeatNote=ANK 1
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341876_1905291.33333333333332472.0RepeatNote=ANK 2
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341909_1939291.33333333333332472.0RepeatNote=ANK 3
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341943_1972291.33333333333332472.0RepeatNote=ANK 4
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341976_2005291.33333333333332472.0RepeatNote=ANK 5
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464342009_2038291.33333333333332472.0RepeatNote=ANK 6
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341699_2471291.33333333333332472.0Topological domainCytoplasmic
TgeneNOTCH2chr1:117492194chr1:120512367ENST000002566464341678_1698291.33333333333332472.0TransmembraneHelical

- Not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49406_536404.3333333333333880.0DomainNote=Ig-like C2-type 4
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49544_662404.3333333333333880.0DomainNote=Ig-like C2-type 5
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49688_813404.3333333333333880.0DomainNote=Ig-like C2-type 6
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49424_427404.3333333333333880.0MotifNote=Endoplasmic reticulum retention signal
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49703_705404.3333333333333880.0MotifCell attachment site
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+4926_832404.3333333333333880.0Topological domainExtracellular
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49854_879404.3333333333333880.0Topological domainCytoplasmic
HgenePTGFRNchr1:117492194chr1:120512367ENST00000393203+49833_853404.3333333333333880.0TransmembraneHelical
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434105_143291.33333333333332472.0DomainEGF-like 3
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434144_180291.33333333333332472.0DomainEGF-like 4
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434182_219291.33333333333332472.0DomainEGF-like 5%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434221_258291.33333333333332472.0DomainEGF-like 6
TgeneNOTCH2chr1:117492194chr1:120512367ENST00000256646434260_296291.33333333333332472.0DomainEGF-like 7%3B calcium-binding
TgeneNOTCH2chr1:117492194chr1:120512367ENST0000025664643426_63291.33333333333332472.0DomainEGF-like 1
TgeneNOTCH2chr1:117492194chr1:120512367ENST0000025664643464_102291.33333333333332472.0DomainEGF-like 2
TgeneNOTCH2chr1:117492194chr1:120512367ENST0000025664643426_1677291.33333333333332472.0Topological domainExtracellular


Top

Fusion Protein-Protein Interaction


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160)
GenePPI interactors


check button Protein-protein interactors based on sequence similarity (STRING)
GeneSTRING network
PTGFRN
NOTCH2


check button - Retained interactions in fusion protein (protein functional feature from UniProt).
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost interactions due to fusion (protein functional feature from UniProt).
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs to PTGFRN-NOTCH2


check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PTGFRN-NOTCH2


check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource